Emerging Strategies to Enhance Oral Bioavailability of Poorly Water-soluble Drugs: From Bcs Classification to Advanced Delivery Systems
Year: 2026
Type: article
Abstract: Pharmaceutical nanotechnology has emerged as a powerful approach in modern drug development, addressing critical limitations associated with conventional drug delivery systems such as poor solubility, low bioavailability, and systemic toxicity. Lipid-based and polymeric nanocarriers have gained significant importance due to their ability to enhance drug stability, improve targeted delivery, and provide controlled release. Lipid nanocarriers, including liposomes, solid lipid nanoparticles (SLNs), and nanostructured lipid carriers (NLCs), offer excellent biocompatibility and high drug encapsulation efficiency. Polymeric nanocarriers such as polymeric nanoparticles, micelles, and dendrimers enable sustained release and site-specific targeting. These systems significantly improve therapeutic outcomes while reducing adverse effects and enhancing patient compliance. This review discusses classification, mechanisms, advantages, applications, and future prospects of lipid and polymeric nanocarriers in pharmaceutical sciences. Keywords: Pharmaceutical nanotechnology, Lipid nanocarriers, Polymeric nanoparticles, Targeted drug delivery, Controlled release, Drug development
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7140042406
